Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiviral therapy in infants with HBV infection (LAM ± interferon vs observation)
ChiCTR2400087363Phase 4Not yet recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jul 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lamivudine and interferon alfa in Chronic Hepatitis B (CHB) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: HBsAg loss rate. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
lamivudineinterferon alfa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2400087363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087363.